These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 22419236

  • 21. Effect of body mass index on bleeding frequency and activated partial thromboplastin time in weight-based dosing of unfractionated heparin: a retrospective cohort study.
    Bauer SR, Ou NN, Dreesman BJ, Armon JJ, Anderson JA, Cha SS, Oyen LJ.
    Mayo Clin Proc; 2009 Dec; 84(12):1073-8. PubMed ID: 19955244
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Performance Assessment of a Multifaceted Unfractionated Heparin Dosing Protocol in Adult Patients on Extracorporeal Membrane Oxygenator.
    Al-Jazairi A, Raslan S, Al-Mehizia R, Dalaty HA, De Vol EB, Saad E, Alanazi M, Owaidah T.
    Ann Pharmacother; 2021 May; 55(5):592-604. PubMed ID: 32959678
    [Abstract] [Full Text] [Related]

  • 25. Comparison between activated clotting time and anti-activated factor X activity for the monitoring of unfractionated heparin therapy in patients with aortic aneurysm undergoing an endovascular procedure.
    Dieplinger B, Egger M, Luft C, Hinterreiter F, Pernerstorfer T, Haltmayer M, Mueller T.
    J Vasc Surg; 2018 Aug; 68(2):400-407. PubMed ID: 29571622
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Risk factors affecting hemorrhage after tooth extraction in patients undergoing continuous infusion with unfractionated heparin.
    Morimoto Y, Niwa H, Minematsu K.
    J Oral Maxillofac Surg; 2012 Mar; 70(3):521-6. PubMed ID: 22177816
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Activated partial thromboplastin time and anti-xa measurements in heparin monitoring: biochemical basis for discordance.
    Takemoto CM, Streiff MB, Shermock KM, Kraus PS, Chen J, Jani J, Kickler T.
    Am J Clin Pathol; 2013 Apr; 139(4):450-6. PubMed ID: 23525615
    [Abstract] [Full Text] [Related]

  • 33. Comparison of 2 weight-based heparin dosing nomograms in neurology and vascular surgical patients.
    Marotti SB, Barras M, Kirkpatrick C.
    Ther Drug Monit; 2015 Feb; 37(1):33-9. PubMed ID: 24831654
    [Abstract] [Full Text] [Related]

  • 34. Epidurals in patients receiving thromboprophylaxis with unfractionated heparin three times a day: the value of activated partial thromboplastin time testing.
    Pace M, Koury K, Gulur P.
    Anesth Analg; 2014 Nov; 119(5):1215-8. PubMed ID: 25225890
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Individualized anticoagulation with dermatan sulphate for haemodialysis in chronic renal failure.
    Boccardo P, Melacini D, Rota S, Mecca G, Boletta A, Casiraghi F, Gianese F.
    Nephrol Dial Transplant; 1997 Nov; 12(11):2349-54. PubMed ID: 9394322
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Unfractionated heparin infusion for treatment of venous thromboembolism based on actual body weight without dose capping.
    Shlensky JA, Thurber KM, O'Meara JG, Ou NN, Osborn JL, Dierkhising RA, Mara KC, Bierle DM, Daniels PR.
    Vasc Med; 2020 Feb; 25(1):47-54. PubMed ID: 31623539
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.